Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Sonus Pharmaceuticals (NasdaqNM:SNUS)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Recent Events
Aug 13Price hit new 52-week high ($4.59)
Location
22026 20th Avenue, S.E.
Bothell, WA 98021
Phone: (425) 487-9500
Fax: (425) 489-0626
Email: sonusem@sonuspharma.com
Employees (last reported count): 30
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Websites
 ·Home Page
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 30%
·Institutional: 12% (18% of float)
(22 institutions)
·Net Inst. Buying: 763.0K shares (+34.95%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Sonus Pharmaceuticals Inc. is engaged in the research and development of therapeutic drug delivery and oxygen delivery products utilizing its core technology in emulsion formulations and surfactant chemistry. Based on this proprietary core technology, the Company has developed the TOCOSOL drug delivery system to solubilize therapeutic drugs that are poorly soluble in water. The Company is developing a cancer therapy product and a cardiovascular therapy product using the TOCOSOL technology. The Company is also developing an oxygen delivery product based on core technology that utilizes stabilized fluorocarbon gas microbubbles to more efficiently transport oxygen to body tissues.
More from Market Guide: Expanded Business Description

Financial Summary
Sonus Pharmaceuticals is engaged in the research and development of therapeutic drug delivery products based on its emulsion formulation technology. For the six months ended 6/30/01, revenues rose from $45 thousand to $1.2 million. Net loss rose from $94 thousand to $2.5 million. Revenues reflect a $1 million ultrasound contrast patent license fee payment from Chugai. Net loss reflects the absence of $4.3 million received from patent litigation and insurance settlements in the prior period.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

Michael Martino, 45
Pres, CEO, Director
$250K
Richard Klein, 38
CFO, VP-Fin.
146K
Nagesh Palepu
Sr. VP, CTO, Chief Scientific Officer
--  
John Flaherty, M.D., 59
Sr. VP and CMO
--  
Gordon Brandt, M.D., 41
VP, Clinical and Regulatory Affairs
--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:SNUSAs of 31-Aug-2001
Price and Volume
52-Week Low
on 21-Dec-2000
$0.406
Recent Price$4.27 
52-Week High
on 13-Aug-2001
$4.59 
Beta0.68 
Daily Volume (3-month avg)45.5K
Daily Volume (10-day avg)64.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change+10.2%
52-Week Change
relative to S&P500
+47.8%
Share-Related Items
Market Capitalization$48.6M
Shares Outstanding11.4M
Float8.00M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$0.93 
Earnings (ttm)-$0.49 
Earnings (mrq)-$0.18 
Sales (ttm)$0.17 
Cash (mrq)$1.05 
Valuation Ratios
Price/Book (mrq)4.61 
Price/EarningsN/A 
Price/Sales (ttm)25.86 
Income Statements
Sales (ttm)$1.55M
EBITDA (ttm)-$4.69M
Income available to common (ttm)-$4.54M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-30.06%
Return on Equity (ttm)-49.55%
Financial Strength
Current Ratio (mrq)5.53 
Debt/Equity (mrq)0 
Total Cash (mrq)$12.0M
Short Interest
As of 8-Aug-2001
Shares Short8,000 
Percent of Float0.1%
Shares Short
(Prior Month)
15.0K
Short Ratio0.19 
Daily Volume42.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.